๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Clinical Trial Report: Treatment of Nonalcoholic Steatohepatitis with Vitamin E

โœ Scribed by Bruce R. Bacon


Book ID
107538618
Publisher
Springer
Year
2010
Tongue
English
Weight
59 KB
Volume
13
Category
Article
ISSN
1522-8037

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Ursodeoxycholic acid for treatment of no
โœ Keith D. Lindor; Kris V. Kowdley; E. Jenny Heathcote; M. Edwyn Harrison; Roberta ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views

No effective medical therapy is available for all patients with nonalcoholic steatohepatitis (NASH). Ursodeoxycholic acid (UDCA) has been suggested to be of benefit based on open label clinical studies. We randomized 166 patients with liver biopsy-proven NASH to receive between 13 and 15 mg/kg/d of

STATISTICAL REPORTING OF CLINICAL TRIALS
โœ IAN R. WHITE; STUART J. POCOCK ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 977 KB

We consider clinical trials in which information is available about subjects' treatment changes after randomization. To understand whether any difference between randomized groups in the intention-to-treat analysis can be explained by such treatment changes, we need analysis strategies which take ac

Results of a phase-II clinical trial on
โœ E. M. Lemmel; M. Franke; W. Gaus; P. W. Hartl; P. H. Hofschneider; K. Miehlke; K ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 552 KB

In an open, non-randomized clinical trial conducted at multiple centres, 49 patients with rheumatoid arthritis were treated with recombinant interferon-gamma for 20 days. The study was carried out in two sub-studies. In the first, the total daily dose of interferon-gamma was 50 micrograms; in the se